116 related articles for article (PubMed ID: 9065878)
21. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride.
Antonini A; Leenders KL; Reist H; Thomann R; Beer HF; Locher J
Arch Neurol; 1993 May; 50(5):474-80. PubMed ID: 8489403
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
[TBL] [Abstract][Full Text] [Related]
23. Savoxepine: striatal dopamine-D2 receptor occupancy in human volunteers measured using positron emission tomography (PET).
Leenders KL; Antonini A; Thomann R; Locher JT; Maître L; Gerebtzoff A; Beer HF; Ametamey S; Weinreich R; Gut A
Eur J Clin Pharmacol; 1993; 44(2):135-40. PubMed ID: 8095895
[TBL] [Abstract][Full Text] [Related]
24. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study.
Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ
Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086
[TBL] [Abstract][Full Text] [Related]
25. Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
Hagelberg N; Forssell H; Rinne JO; Scheinin H; Taiminen T; Aalto S; Luutonen S; Någren K; Jääskeläinen S
Pain; 2003 Jan; 101(1-2):149-54. PubMed ID: 12507709
[TBL] [Abstract][Full Text] [Related]
26. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.
Vollenweider FX; Vontobel P; Oye I; Hell D; Leenders KL
J Psychiatr Res; 2000; 34(1):35-43. PubMed ID: 10696831
[TBL] [Abstract][Full Text] [Related]
27. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Baldessarini RJ
Neuroscience; 1998 Nov; 87(1):1-4. PubMed ID: 9722137
[TBL] [Abstract][Full Text] [Related]
28. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum.
Berendse HW; Richfield EK
Neurosci Lett; 1993 Feb; 150(1):75-9. PubMed ID: 8097026
[TBL] [Abstract][Full Text] [Related]
30. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Sakamoto M
Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989
[TBL] [Abstract][Full Text] [Related]
31. Altered dopamine D2 receptor binding in atypical facial pain.
Hagelberg N; Forssell H; Aalto S; Rinne JO; Scheinin H; Taiminen T; Någren K; Eskola O; Jääskeläinen SK
Pain; 2003 Nov; 106(1-2):43-8. PubMed ID: 14581109
[TBL] [Abstract][Full Text] [Related]
32. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Antonini A; Schwarz J; Oertel WH; Beer HF; Madeja UD; Leenders KL
Neurology; 1994 Jul; 44(7):1325-9. PubMed ID: 8035939
[TBL] [Abstract][Full Text] [Related]
33. Striatal dopamine distribution in parkinsonian patients during life.
Nahmias C; Garnett ES; Firnau G; Lang A
J Neurol Sci; 1985 Jul; 69(3):223-30. PubMed ID: 3928823
[TBL] [Abstract][Full Text] [Related]
34. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
[TBL] [Abstract][Full Text] [Related]
35. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
Antonini A; Leenders KL
Ann N Y Acad Sci; 1993 Sep; 695():81-5. PubMed ID: 8239318
[TBL] [Abstract][Full Text] [Related]
36. The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI.
Wagner AK; Scanlon JM; Becker CR; Ritter AC; Niyonkuru C; Dixon CE; Conley YP; Price JC
J Cereb Blood Flow Metab; 2014 Aug; 34(8):1328-39. PubMed ID: 24849661
[TBL] [Abstract][Full Text] [Related]
37. D1 and D2 dopamine receptors in perinatal and adult basal ganglia.
Boyson SJ; Adams CE
Pediatr Res; 1997 Jun; 41(6):822-31. PubMed ID: 9167195
[TBL] [Abstract][Full Text] [Related]
38. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Karlsson P; Farde L; Halldin C; Swahn CG; Sedvall G; Foged C; Hansen KT; Skrumsager B
Psychopharmacology (Berl); 1993; 113(2):149-56. PubMed ID: 7855175
[TBL] [Abstract][Full Text] [Related]
39. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
40. N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic.
Hagberg G; Gefvert O; Bergström M; Wieselgren IM; Lindström L; Wiesel FA; Långström B
Psychiatry Res; 1998 Jun; 82(3):147-60. PubMed ID: 9754439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
